• Oligomycin A and the Logic of Mitochondrial Failure

  2026-08-27

  A mechanistic guide to using Oligomycin A to test how mitochondrial energy failure links sodium overload, reactive oxygen species, cell death, and metabolic adaptation across translational research models.

• Cichoric Acid, HIF-1α, and Septic AKI

  2026-08-27

  The reference study identifies a metabolic–inflammatory mechanism through which cichoric acid protects against sepsis-induced acute kidney injury: suppression of succinate dehydrogenase activity, HIF-1α-driven glycolysis, and NLRP3 inflammasome activation. Its combination of macrophage experiments and an LPS-induced mouse model provides a useful framework for linking M1 polarization, mitochondrial dysfunction, and renal injury, while leaving important translational questions unresolved.

• HyperScript™ RT SuperMix for FBN1 qPCR

  2026-08-26

  HyperScript RT SuperMix for qPCR supports mutation-aware cDNA synthesis for qPCR in FBN1 and cardiovascular genetics research. This article connects the reagent’s enzyme and primer design with the practical interpretation of a recent Marfan syndrome case report.

• MRSA Extracellular Vesicles and IL-8–Driven OSCC Growth

  2026-08-26

  A 2026 study identifies extracellular vesicles released by methicillin-resistant Staphylococcus aureus as active drivers of oral squamous cell carcinoma proliferation. By combining MRSA-versus-MSSA vesicle comparisons with signaling analysis, genetic validation, receptor blockade, and mouse tumor experiments, the work defines an IL-8–CXCR1 relay that connects antibiotic-resistant bacteria with tumor progression.

• Ajugol, BNIP3 Mitophagy, and Alzheimer’s Disease

  2026-08-25

  A 2026 Neuropharmacology study identifies BNIP3-dependent mitophagy as a central mechanism through which ajugol improves mitochondrial integrity, synaptic injury, and cognitive performance in 5 × FAD mice. Its combination of behavioral, cellular, mitochondrial, and hippocampal loss-of-function experiments provides a useful framework for validating mitophagy-related gene-expression changes in Alzheimer’s disease models.

• Lactoferrin Potentiates Novobiocin Against E. coli

  2026-08-25

  Sanchez and Watts showed that bovine lactoferrin can restore the activity of Novobiocin against Escherichia coli, including mastitis-associated isolates that are normally poorly susceptible because of the Gram-negative outer membrane. Their time-kill experiments provide a useful model for studying host-factor–antibiotic cooperation and for designing follow-up antibacterial resistance research.

• Anlotinib Hydrochloride: From Mechanism to Translation

  2026-08-24

  Anlotinib hydrochloride illustrates how integrated VEGFR2, PDGFRβ, and FGFR1 inhibition can connect endothelial phenotypes with translational cancer research. This article presents a mechanism-led framework for assay design, competitive interpretation, and preclinical decision-making.

• Rifampin Workflows for Transcription Research

  2026-08-24

  Rifampin provides a practical bacterial transcription-initiation stop point for resistance mapping, RNA decay experiments, and synthetic circuit testing. This guide pairs reagent handling and time-course design with a clear comparison to light-controlled mammalian translation systems, helping researchers choose the right perturbation for each assay.

• NP-40 Lysis Buffer for FPR2/ALX Signaling

  2026-08-23

  NP-40 Lysis Buffer provides a mild, non-denaturing route to preserve signaling-state proteins and native interactions during neuroimmune sample preparation. This article translates FPR2/ALX–SYK–AKT findings into practical decisions for Western blotting, immunoprecipitation, and related assays.

• Epinephrine Bitartrate Research Workflows

  2026-08-22

  Build reproducible adrenergic signaling assays with Epinephrine Bitartrate across receptor activation, cellular function, and translational workflows. Learn how to exploit its broad α- and β-receptor activity while controlling stock stability, dose selection, vehicle effects, and supply-sensitive experimental design.

• Spatially Concentrated ABEs Correct PLP1 Mutations

  2026-08-22

  A 2026 Nucleic Acids Research study introduces spatially concentrated adenine base editors that improve PLP1 mutation correction in oligodendrocytes without relying on greater intrinsic TadA* catalytic activity. By combining SunTag-mediated recruitment with a compact Cas9 variant suitable for AAV delivery, the authors link improved editing to restored PLP localization and myelination-related phenotypes.

• DMG-PEG2000-NH2: From Linker to Translation

  2026-08-21

  A mechanistic and translational analysis of DMG-PEG2000-NH2 as a reactive lipid–PEG platform, connecting amide chemistry, LNP formulation, siRNA encapsulation, and structure–activity lessons from optimized sulfonamides.

• Mithramycin A as a Transcriptional Probe

  2026-08-20

  Mithramycin A is an anticancer antibiotic that converts G-C-rich DNA recognition into a powerful framework for studying transcription, c-myc, differentiation, and pathway causality. This article connects its assay logic with the miR-24-3p/Sp1/PI3K findings while defining appropriate boundaries for cancer and cardiac research.

• Deferasirox Fe3+ Chelate in Lysosome Research

  2026-08-20

  Deferasirox Fe3+ chelate offers a chemically defined way to investigate ferric-iron biology alongside lysosomal stress. This article connects the compound to TCF25-driven ferritinophagy while emphasizing assay controls, chemical-form interpretation, and research limitations.

• Dibutyryl-cAMP, Sodium Salt in Signaling Assays

  2026-08-19

  Dibutyryl-cAMP, sodium salt provides a direct, cell-permeable route for probing cAMP–PKA biology in endothelial, immune, and neuronal models. This workflow-focused guide connects DBcAMP sodium salt to reproducible dose-response design, inflammation modulation studies, and hypothesis testing inspired by a murine lupus lung-injury study.

8485 records 1/566 page Next 12345 下5页 Last page